The Pharmaceutical Care Network Europe (PCNE) was established in 1994 and it became an official association (under Dutch law) in 2004.
Pharmaceutical Care is the pharmacist's contribution to the care of individuals, in order to optimize medicines use and improve health outcomes.
The Pharmaceutical Care Network Europe is an active association, with three working groups
In order to advance the work of the Working Groups, they must meet regularly. Therefore we have organised this Working Symposium in Malta in 2014, where non-members also were welcome.
In the wonderful setting of this old island, we presented and discussed the recent developments in all three fields, suggested to adapt classifications, declarations and definitions. We had a wonderful seaside hotel for this event.
After two days of working group meetings, we also had a General Assembly of the Association where we welcomed new applicants for membership. During tea and coffee breaks, participants could exchange information about their activities.
The slides of the lectures and reports of the meetings of the Working Groups will gradually appear. Please see under the tab 'Workshops' above, for the reports of the sessions.
Prof. Dr. Kurt Hersberger,
PCNE Chairman
Basle, Switzerland
PCNE welcomed SPINGER Science and Business Media and Hilary Cordina as valued sponsors.
Conference committee: Charlotte Rossing, Denmark; Nina Griese, Germany; Veerle Foulon, Belgium; Foppe van Mil, the Netherlands; Kurt Hersberger, Switzerland (Chair).
Organisation: Maria Cordina (Malta) and Foppe van Mil (Professional Secretary PCNE)
Contact: info@pcne.org
Abstract review committee: Prof. K. Hersberger, Dr. N. Griese-Mammen, Dr. V. Foulon, Dr. C. Rossing, Dr. M. Cordina
All sesions (on DRPs, Medication Review, and Pharmaceutical Care Guidelines and Standards) consisted of a number of lectures, plus workshops.
(Friday 14th March Morning)
1. The PCNE-DRP classification for beginners
In this workshops the participants will learn how the classification works, what the domains, and options for use are, and how to score drug-related problems with the help of the classification V6.2. (Facilitator: Arijana Meštrović)
2. The PCNE-DRP classification for experienced users
In this workshop the participants will complete a set of cases for validation purposed. The scoringand the system V 6.2will then be evaluated with the participants. (Facilitators: Markus Messerli and Samuel Alleman)
3. Improving thePCNE-DRP classification V6.2
This workshop is for more-or less exprienced users of the classification, and will try to evaluate the current version as an aid to future improvements for a version 7 (or 6.3). (Facilitator: Foppe van Mil)
4. Validating a Drug-related problem classification
This workshop is for experience researchers. Participants will discuss which elements of a DRP classification need validation, and what would be the best methods to carry out this validation. (Facilitators: Kurt Hersberger, Carole Kaufmann, Karen Maes)
(Friday 14th March afternoon)
Click here to download the program report >>
1. PCNE milestones for medication review
This workshop is for PCNE members and participants who intend to become a member. Participants will discuss what they as a member expect from PCNE with regard to medication review and its further development. (Facilitator: Martin Henman)
2. Finalizing the PCNE definition of medication review
This workshop is for participants who have been already involved in PCNE medication review workshops and discussions. PCNE has held several workshops and symposia on the topic. During these workshops and symposia a definition was developed. The participants will discuss the PCNE definition of medication review with the aim of finalization this definition for PCNE statements . (Facilitator: Nina Griese and Kurt Hersberger)
3. DRP and medication review: Which DRP can be detected with level I and 2a
This workshop is both for beginners and for experienced researchers. On the basis the results of the PCNE workshop Berlin and the PCNE-DRP classification the participants will complete a list of DRP that can be detected with these levels.(Facilitator: Saija Leikola)
4. DRP and medication review: Which DRP can be detected with level 2b
This workshop is both for beginners and for experienced researchers. On the basis the results of the PCNE workshop in Berlin and the PCNE-DRP classification the participants will complete a list of DRP that can be detected with these levels.
(Facilitator: Markus Messerli and Lea Botermann)
(Saturday 15th March, 13-16.00h)
A World Café! Participants will be divided into smaller groups to discuss the different roles PCNE could take in the future work concerning guidelines and standards, and to start this work.
Themes for the different groups:
- Writing disease-specific guidelines
- Writing guidelines on processes
- Developing methodology to achieve valid guidelines
8.00-9.00 Registration
9.00-9.15 Opening (Prof. Kurt Hersberger)
9.15-13.00 Drug Related Problems (Dr. Foppe van Mil & Markus Messerli, chairs)
9.15-9.30 The PCNE-DRP classification, history and projects (Foppe van Mil, the Netherlands)
9.30-9.45 Using the PCNEclassification in Belgium (Dr. Isabelle de Wulf, Belgium) - Abstract
9.45-10.00 Using the PCNE classification in Continuing Professional Development (Dr. Arijana Mestrovic, Croatia) - Abstract
10.00-10.15 Creating and validating a DRP classification. (Ms. Karen Maes, Switzerland) - Abstract
10.15-11.00 Workshops & group-discussions on Drug-related problem classifications [Part 1]. See the tab 'Workshops'.
11.00-11.30 Coffee break and Posters
11.30-12.30 Workshops & group-discussions on Drug-related problem classifications [Continued].
12.30-13.00 Workshop reports and closure
13.00-14.00 Lunch and posters
14.00-18.00 PCNE and medication review (Dr. Nina Griese & Saija Leikola, chairs)
14:00 – 14:10 Introduction (Nina Griese, Germany)
14:10 – 14:30 PCNE definition of medication review and the achievements of the Berlin working conference (Saija Leikola, Finland)
14:30 – 14:50 Exploratory study of pharmacist-led home medication use reviews (HMUR) for elderly people in collaboration with family doctors and home care nurses (Olivier Bugnon, Switzerland)
14:50 – 15:10 Implementation and evaluation of a new multidisciplinary guideline on polypharmacy in the Netherlands (Menno van Woerkom, Netherlands) - Abstract
15:10 – 15:30 GeriMed, a medication review programme for nursing homes (Manfred Krüger, Germany)
15:30 – 15:50 Medication review - focus inappropriate medications - for the elderly patients in an intermediate care unit in primary care (Kirsten Viktil, Norway)
15:50 – 16:00 Introduction: topics of working groups
16:00 – 16:30 Tea break and posters
16:30 – 17:30 Discussion in smaller groups
17:30 – 18:00 Presentation of results and discussion
18.00-18.30 Wrap-up of day one Prof. Kurt Hersberger)
Dinner at participants’ expenses (and choice)
The purpose of the day is to get an overview on the work that has been done regarding the development of pharmaceutical care guidelines and standards, and to debate the different approaches PCNE could take to this work.
9 - 9.15 Welcome and outline of the purpose of the day
9.15 – 12.00 Examples and Country cases
- Guidelines for general pharmaceutical services and for chronic diseases (Dr. Berry Daemen, the Netherlands)- Abstract
- The case of “Inhalation Check Technique” (Dr. Charlotte Rossing, Denmark) - Presentation
- Belgium: Veerle Foulon: A methodological perspective (Dr. Veerle Foulon, Belgium) - Presentation
- EDQM indicators on Pharmaceutical Care (Dr. Dick Tromp, president Europharm Forum) - Presentation
12.00 -13.00 Lunch and posters
13.00-16.00 Debate (see tab Workshops)
16.00-16.30 Workshop reports & plenary discussion, including concusions on future work for PCNE
16.30-18.30 Members soapbox (new): An exchange of PCNE members projects and publications (PCNE members only)
Dinner
19.30 Departure to PCNE anniversary dinner by bus (transfer included in fee)
20.00- ........ ? PCNE anniversary dinner (20 years, separate registration, fully booked)
9.00-13.00 PCNE General Assembly (members only) incl. coffee break
Accepted and presented abstracts are published in the International Journal of Clinical Pharmacy in 2014 after the Symposium.
List of accepted abstracts (click on the title to see the abstract)
ID | Title | Scope | Country | Organization |
1437 |
Omission Impossible; A Snapshot of Medication Dose Omissions in an Australian Teaching Hospital |
DRP |
Australia |
The University of Western Australia |
1438 |
Improving the management of anaphylaxis in the community: are action plans the key? |
Guidelines |
Australia |
The University of Western Australia |
1439 |
Guidelines |
Australia |
The University of Western Australia |
|
1444 |
Medication Review |
Portugal |
ISCSEM |
|
1445 |
Drug relation problems in Polish patients with chronic illness. |
DRP |
Poland |
Department of Social Pharmacy, Faculty of Pharmacy, Jagiellonian University, Krakow, POLAND |
1446 |
Guidelines |
Netherlands |
KNMP Den Haag, RadboudUMC Nijmegen |
|
1447 |
DRP |
Other |
Governmental Health Office in District Karanganyar, Central Java Province, Indonesia |
|
1448 |
Evaluation of a Danish pharmacist student-physician medication review collaboration model |
Medication Review |
Denmark |
Department of Pharmacy, Faculty of Health and Medical Science, University of Copenhagen |
1449 |
Medication Review |
Slovenia |
Chair of Social Pharmacy, University of Ljubljana- Faculty of pharmacy |
|
1450 |
Guidelines |
Malta |
Department of Pharmacy, University of Malta |
|
1451 |
Medication Review |
Denmark |
Copenhagen University, Denmark |
|
1452 |
Evolution of Pharmaceutical Care definitions: The PCNE definition 2013 |
Guidelines |
Switzerland |
University of Basel, Switzerland |
1453 |
Guidelines |
Malta |
Department of Pharmacy, University of Malta |
|
1454 |
Medication Review |
Norway |
Hospital Pharmacy of North Norway, Tromsø, Norway |
|
1455 |
DRP |
Spain |
Pharmacy Department-Hospital del Mar, Barcelona, Spain |
|
1456 |
Medication Review |
Other |
Pharmacy & Drug Control Department, Supreme Council of Health, Doha-Qatar |
|
1457 |
Medication Review |
Netherlands |
VU University Medical Center, Department of Clinical Pharmacology |
|
1458 |
DRP |
Malta |
Department of Pharmacy, Faculty of Medicine and Surgery, University of Malta |
|
1459 |
Development and validation of medication assessment tools specific for rheumatoid arthritis |
Guidelines |
Malta |
Department of Pharmacy, Faculty of Medicine and Surgery, University of Malta |
1460 |
Validation and adaptation of The PCNE Classification V 6.2 for use in Slovenian community pharmacies |
DRP |
Slovenia |
Chair of Social Pharmacy, University of Ljubljana- Faculty of pharmacy |
1461 |
Classification for pharmaceutical interventions in patient oriented care: a new concept |
DRP |
Switzerland |
Pharmaceutical Care Research Group, University of Basel, Switzerland |
1463 |
Evaluation of drug related problems in Belgium : focus on corticosteroids |
DRP |
Belgium |
Laboratory of Pharmaceutics and Biopharmaceutics, Faculté de Pharmacie, Université Libre de Bruxelle |
1464 |
Evaluation of a drug related problem classification tool in community pharmacy daily practice |
DRP |
Belgium |
Laboratory of Pharmaceutics and Biopharmaceutics, Faculté de Pharmacie, Université Libre de Bruxelle |
1465 |
Medication Review |
Switzerland |
Pharmaceutical Care Research Group, University of Basel, Switzerland |
|
1466 |
DRP |
Poland |
Department of Social Pharmacy, Jagiellonian University Collegium Medicum, Krakow, Poland |
|
1467 |
Guidelines |
Hungary |
University of Szeged, Faculty of Pharmacy, Institute of Drug Regulatory Affairs |